SCHEMBL734846

SCHEMBL734846

CCCCC1(N(C)C)CC=C(c2[nH]c3ccc(OC(F)(F)F)cc3c2C)CC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
KIF11 P52732 1/20 0.33
ALOX5 P09917 1/20 0.32
HTR1D P28221 2/20 0.32
HTR1B P28222 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 1/20 0.32
NR1I2 O75469 1/20 0.31
MEN1 O00255 4/20 0.31
KMT2A Q03164 4/20 0.31
CCNT1 O60563 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
CDK9 P50750 1/20 0.31
POLB P06746 1/20 0.31
PTGS2 P35354 2/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734337 0.89 ALOX5 (0.41) KDM4EALOX5HTR1DALDH1A1HPGD
SCHEMBL733907 0.86 MEN1 (0.38) KIF11MEN1KMT2AHTR2AHTR2C
SCHEMBL735401 0.85 OPRM1 (0.39) KDM4EHSD17B10MEN1KMT2APOLB
SCHEMBL734664 0.85 KIF11 (0.37) KDM4ECRHBPCRHR2KIF11ALOX5
SCHEMBL734534 0.81 OPRM1 (0.39) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL735115 0.80 MEN1 (0.37) MEN1KMT2ACDK2CYP2C9
SCHEMBL734201 0.78 OPRM1 (0.43) KDM4ECRHBPCRHR2KIF11
SCHEMBL734177 0.77 KDM4E (0.35) KDM4ECRHBPCRHR2KIF11HTR1D
SCHEMBL736437 0.73 KMT2A (0.46) KDM4EALOX5HTR1DALDH1A1HPGD
SCHEMBL733728 0.72 HTR2A (0.39) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 KDM4E 2643/4885CRHBP 4214/4885CRHR2 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.